BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 12000789)

  • 1. Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse.
    Kalamarides M; Niwa-Kawakita M; Leblois H; Abramowski V; Perricaudet M; Janin A; Thomas G; Gutmann DH; Giovannini M
    Genes Dev; 2002 May; 16(9):1060-5. PubMed ID: 12000789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meningioma progression in mice triggered by Nf2 and Cdkn2ab inactivation.
    Peyre M; Stemmer-Rachamimov A; Clermont-Taranchon E; Quentin S; El-Taraya N; Walczak C; Volk A; Niwa-Kawakita M; Karboul N; Giovannini M; Kalamarides M
    Oncogene; 2013 Sep; 32(36):4264-72. PubMed ID: 23045274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations.
    Kalamarides M; Stemmer-Rachamimov AO; Takahashi M; Han ZY; Chareyre F; Niwa-Kawakita M; Black PM; Carroll RS; Giovannini M
    Brain Pathol; 2008 Jan; 18(1):62-70. PubMed ID: 17924978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of PTPRJ/DEP-1 enhances NF2/Merlin-dependent meningioma development.
    Waldt N; Scharnetzki D; Kesseler C; Kirches E; Stroscher N; Böhmer FD; Mawrin C
    J Neurol Sci; 2020 Jan; 408():116553. PubMed ID: 31715329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas.
    Dickinson PJ; Surace EI; Cambell M; Higgins RJ; Leutenegger CM; Bollen AW; LeCouteur RA; Gutmann DH
    Vet Pathol; 2009 Sep; 46(5):884-92. PubMed ID: 19429976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PDGF activation in PGDS-positive arachnoid cells induces meningioma formation in mice promoting tumor progression in combination with Nf2 and Cdkn2ab loss.
    Peyre M; Salaud C; Clermont-Taranchon E; Niwa-Kawakita M; Goutagny S; Mawrin C; Giovannini M; Kalamarides M
    Oncotarget; 2015 Oct; 6(32):32713-22. PubMed ID: 26418719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling NF2 with human arachnoidal and meningioma cell culture systems: NF2 silencing reflects the benign character of tumor growth.
    James MF; Lelke JM; Maccollin M; Plotkin SR; Stemmer-Rachamimov AO; Ramesh V; Gusella JF
    Neurobiol Dis; 2008 Feb; 29(2):278-92. PubMed ID: 17962031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus.
    Hansson CM; Buckley PG; Grigelioniene G; Piotrowski A; Hellström AR; Mantripragada K; Jarbo C; Mathiesen T; Dumanski JP
    BMC Genomics; 2007 Jan; 8():16. PubMed ID: 17222329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Merlin expression in secretory meningiomas: evidence of an NF2-independent pathogenesis? Immunohistochemical study.
    Buccoliero AM; Gheri CF; Castiglione F; Ammannati F; Gallina P; Taddei A; Garbini F; Rossi Degl'Innocenti D; Arganini L; Di Lorenzo N; Mennonna P; Taddei GL
    Appl Immunohistochem Mol Morphol; 2007 Sep; 15(3):353-7. PubMed ID: 17721284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational analysis of the NF2 gene in sporadic meningiomas by denaturing high-performance liquid chromatography.
    Kim JH; Kim IS; Kwon SY; Jang BC; Suh SI; Shin DH; Jeon CH; Son EI; Kim SP
    Int J Mol Med; 2006 Jul; 18(1):27-32. PubMed ID: 16786152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of NF2 gene deletion in pediatric meningiomas using chromogenic in situ hybridization.
    Begnami MD; Rushing EJ; Santi M; Quezado M
    Int J Surg Pathol; 2007 Apr; 15(2):110-5. PubMed ID: 17478763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic.
    Williams EA; Santagata S; Wakimoto H; Shankar GM; Barker FG; Sharaf R; Reddy A; Spear P; Alexander BM; Ross JS; Brastianos PK; Cahill DP; Ramkissoon SH; Juratli TA
    Acta Neuropathol Commun; 2020 Oct; 8(1):171. PubMed ID: 33087175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of NF2-negative and NF2-positive primary human meningioma cell proliferation by overexpression of merlin due to vector-mediated gene transfer.
    Ikeda K; Saeki Y; Gonzalez-Agosti C; Ramesh V; Chiocca EA
    J Neurosurg; 1999 Jul; 91(1):85-92. PubMed ID: 10389885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic landscape of meningioma.
    Yuzawa S; Nishihara H; Tanaka S
    Brain Tumor Pathol; 2016 Oct; 33(4):237-247. PubMed ID: 27624470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of NF2 gene product merlin in arachnoid villi and meningiomas.
    Sakuda K; Kohda Y; Matsumoto T; Park C; Seto A; Tohma Y; Hasegawa M; Kida S; Nitta H; Yamashima T; Yamashita J
    Noshuyo Byori; 1996 Nov; 13(2):145-8. PubMed ID: 8958521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Essential Role for the Tumor-Suppressor Merlin in Regulating Fatty Acid Synthesis.
    Stepanova DS; Semenova G; Kuo YM; Andrews AJ; Ammoun S; Hanemann CO; Chernoff J
    Cancer Res; 2017 Sep; 77(18):5026-5038. PubMed ID: 28729415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningioma.
    Harada T; Irving RM; Xuereb JH; Barton DE; Hardy DG; Moffat DA; Maher ER
    J Neurosurg; 1996 May; 84(5):847-51. PubMed ID: 8622160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular alterations in the neurofibromatosis type 2 gene and its protein rarely occurring in meningothelial meningiomas.
    Evans JJ; Jeun SS; Lee JH; Harwalkar JA; Shoshan Y; Cowell JK; Golubic M
    J Neurosurg; 2001 Jan; 94(1):111-7. PubMed ID: 11147878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of neurofibromatosis type 2 gene transcripts in meningiomas supports the concept of distinct molecular variants.
    Wellenreuther R; Waha A; Vogel Y; Lenartz D; Schramm J; Wiestler OD; von Deimling A
    Lab Invest; 1997 Dec; 77(6):601-6. PubMed ID: 9426397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth.
    James MF; Han S; Polizzano C; Plotkin SR; Manning BD; Stemmer-Rachamimov AO; Gusella JF; Ramesh V
    Mol Cell Biol; 2009 Aug; 29(15):4250-61. PubMed ID: 19451225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.